minimacs separator ms column (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
96
Structured Review
Miltenyi Biotec
minimacs separator ms column
Minimacs Separator Ms Column, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 496 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/MiniMACS+Separator/pm42538800-68-1-5
Average 96 stars, based on 496 article reviews
Minimacs Separator Ms Column, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 496 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ms/MiniMACS+Separator/pm42538800-68-1-5
Average 96 stars, based on 496 article reviews
minimacs separator ms column - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Magnetic Cell Separation:Article Title: Stepwise Chemically Defined Differentiation of Human iPSCs into Oligodendrocytes with Harvestable Developmental Intermediates. Article Snippet: This article describes a chemically defined stepwise protocol to differentiate human induced pluripotent stem cells (hiPSCs) into mature oligodendrocytes via harvestable developmental intermediates.. The workflow recapitulates in vitro neural lineage specification through embryoid body formation, neuroectoderm induction, the generation of glial-restricted progenitors, and the transition through oligodendrocyte progenitor cells (OPCs) to terminally differentiated, myelinating oligodendrocytes.. Lineage progression is driven exclusively by small molecules and growth factors selected based on developmental and pharmacological evidence, without the use of exogenous transcription factor overexpression. Article Title: A single-nucleus multiomic study of preoptic area cells in prepubertal control vs prenatally androgenized female mice. Article Snippet: 2 Next, 25μL of magnetically labelled anti-nucleus MicroBeads (Miltenyi Biotec, Auburn, CA, USA) 3 were added to positively select intact nuclei and allow removal of cellular debris, and the mixture 4 was incubated end-over-end for 1 hour at 4°C. .. A Article Title: A Novel Magnetically Targeted Intramedullary (MagIC-TI) Xenograft Model for Precise Leukemia Modeling and Drug Resistance Evaluation in the Bone Marrow Niche. Article Snippet: For magnetic labeling, HL60-ADR-GL cells (1× 107 cells/80 μL PBS, 20 μL microbeads) were incubated with CD33 MicroBeads (130-045-501; Miltenyi Biotec, Bergisch Gladbach, Germany) at 2–8°C for 20min according to the manufacturer’s protocol. .. After incubation, cells were washed with PBS and subjected to magnetic separation using an MS MACS column (130-042-201) on a Article Title: Elastogenesis by adventitial progenitors acquiring a smooth muscle cell phenotype following aortic dissection Article Snippet: Sca-1 labeling was conducted directly in the cell suspension using Anti-Sca-1 (non-HSC) MicroBeads (10 μL, #130-106-641, Miltenyi Biotec), and MACS® buffer (1 mL, #130-091-376 and #130-091-221, Miltenyi Biotec) was then added to proceed with magnetic sorting. .. Labeled cells were first filtered through cell strainers (#10199-658, VWR), then separated using MS columns (#130-042-201, Miltenyi Biotec) mounted on a Incubator:Article Title: Stepwise Chemically Defined Differentiation of Human iPSCs into Oligodendrocytes with Harvestable Developmental Intermediates. Article Snippet: This article describes a chemically defined stepwise protocol to differentiate human induced pluripotent stem cells (hiPSCs) into mature oligodendrocytes via harvestable developmental intermediates.. The workflow recapitulates in vitro neural lineage specification through embryoid body formation, neuroectoderm induction, the generation of glial-restricted progenitors, and the transition through oligodendrocyte progenitor cells (OPCs) to terminally differentiated, myelinating oligodendrocytes.. Lineage progression is driven exclusively by small molecules and growth factors selected based on developmental and pharmacological evidence, without the use of exogenous transcription factor overexpression. Mass Spectrometry:Article Title: Stepwise Chemically Defined Differentiation of Human iPSCs into Oligodendrocytes with Harvestable Developmental Intermediates. Article Snippet: This article describes a chemically defined stepwise protocol to differentiate human induced pluripotent stem cells (hiPSCs) into mature oligodendrocytes via harvestable developmental intermediates.. The workflow recapitulates in vitro neural lineage specification through embryoid body formation, neuroectoderm induction, the generation of glial-restricted progenitors, and the transition through oligodendrocyte progenitor cells (OPCs) to terminally differentiated, myelinating oligodendrocytes.. Lineage progression is driven exclusively by small molecules and growth factors selected based on developmental and pharmacological evidence, without the use of exogenous transcription factor overexpression. Flow Cytometry:Article Title: Stepwise Chemically Defined Differentiation of Human iPSCs into Oligodendrocytes with Harvestable Developmental Intermediates. Article Snippet: This article describes a chemically defined stepwise protocol to differentiate human induced pluripotent stem cells (hiPSCs) into mature oligodendrocytes via harvestable developmental intermediates.. The workflow recapitulates in vitro neural lineage specification through embryoid body formation, neuroectoderm induction, the generation of glial-restricted progenitors, and the transition through oligodendrocyte progenitor cells (OPCs) to terminally differentiated, myelinating oligodendrocytes.. Lineage progression is driven exclusively by small molecules and growth factors selected based on developmental and pharmacological evidence, without the use of exogenous transcription factor overexpression. Incubation:Article Title: Age-associated niche remodeling drives dental pulp progenitor dysfunction and fibrosis. Article Snippet: Antibodies used for MACS were LYPD1 (Rabbit, 1:100, Proteintech, 11415-1-AP) and secondary antibody 647 (Goat, 1:300, Abcam, ab150079). .. Cells were then incubated with Alexa Fluor 647 MicroBeads (Miltenyi Biotec, 130-091-395), washed, and subjected to magnetic separation using Article Title: A Novel Magnetically Targeted Intramedullary (MagIC-TI) Xenograft Model for Precise Leukemia Modeling and Drug Resistance Evaluation in the Bone Marrow Niche. Article Snippet: For magnetic labeling, HL60-ADR-GL cells (1× 107 cells/80 μL PBS, 20 μL microbeads) were incubated with CD33 MicroBeads (130-045-501; Miltenyi Biotec, Bergisch Gladbach, Germany) at 2–8°C for 20min according to the manufacturer’s protocol. .. After incubation, cells were washed with PBS and subjected to magnetic separation using an MS MACS column (130-042-201) on a Labeling:Article Title: A Novel Magnetically Targeted Intramedullary (MagIC-TI) Xenograft Model for Precise Leukemia Modeling and Drug Resistance Evaluation in the Bone Marrow Niche. Article Snippet: For magnetic labeling, HL60-ADR-GL cells (1× 107 cells/80 μL PBS, 20 μL microbeads) were incubated with CD33 MicroBeads (130-045-501; Miltenyi Biotec, Bergisch Gladbach, Germany) at 2–8°C for 20min according to the manufacturer’s protocol. .. After incubation, cells were washed with PBS and subjected to magnetic separation using an MS MACS column (130-042-201) on a Article Title: Elastogenesis by adventitial progenitors acquiring a smooth muscle cell phenotype following aortic dissection Article Snippet: Sca-1 labeling was conducted directly in the cell suspension using Anti-Sca-1 (non-HSC) MicroBeads (10 μL, #130-106-641, Miltenyi Biotec), and MACS® buffer (1 mL, #130-091-376 and #130-091-221, Miltenyi Biotec) was then added to proceed with magnetic sorting. .. Labeled cells were first filtered through cell strainers (#10199-658, VWR), then separated using MS columns (#130-042-201, Miltenyi Biotec) mounted on a other:Article Title: Protocol for immunomagnetic enrichment of CD8 T cells from complex murine tissues Article Snippet: |
![Reaction schemes <t>and</t> <t>LC-MS</t> analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of trillin mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3502/pmc13123502/pmc13123502__gr2.jpg)